» Articles » PMID: 22792458

A Hierarchy of Patient-reported Outcomes for Meta-analysis of Knee Osteoarthritis Trials: Empirical Evidence from a Survey of High Impact Journals

Overview
Journal Arthritis
Specialty Rheumatology
Date 2012 Jul 14
PMID 22792458
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives. To develop a prioritised list based on responsiveness for extracting patient-reported outcomes (PROs) measuring pain and disability for performing meta-analyses in knee osteoarthritis (OA). Methods. A systematic search was conducted in 20 highest impact factor general and rheumatology journals chosen a priori. Eligible studies were randomised controlled trials, using two or more PROs measuring pain and/or disability. Results. A literature search identified 402 publications and 38 trials were included, resulting in 54 randomised comparisons. Thirty-five trials had sufficient data on pain and 15 trials on disability. The WOMAC "pain" and "function" subscales were the most responsive composite scores. The following list was developed. Pain: (1) WOMAC "pain" subscale, (2) pain during activity (VAS), (3) pain during walking (VAS), (4) general knee pain (VAS), (5) pain at rest (VAS), (6) other composite pain scales, and (7) other single item measures. Disability: (1) WOMAC "function" subscale, (2) SF-36 "physical function" subscale, (3) SF-36 (Physical composite score), and (4) Other composite disability scores. Conclusions. As choosing the PRO most favourable for the intervention from individual trials can lead to biased estimates, using a prioritised list as developed in this study is recommended to reduce risk of biased selection of PROs in meta-analyses.

Citing Articles

Long-term effectiveness of intra-articular injectables in patients with knee osteoarthritis: a systematic review and Bayesian network meta-analysis.

Gupta N, Khatri K, Lakhani A, Dahuja A, Randhawa A, Bansal V J Orthop Surg Res. 2025; 20(1):227.

PMID: 40025522 PMC: 11874392. DOI: 10.1186/s13018-025-05574-w.


Radiofrequency treatment for chronic knee pain in people with knee osteoarthritis.

Belba A, Vanneste T, Vanlinthout L, Kallewaard J, van Kuijk S, Kimman M Cochrane Database Syst Rev. 2025; 2:CD015865.

PMID: 39918064 PMC: 11803711. DOI: 10.1002/14651858.CD015865.


Ultrasound-guided versus blind arthrocentesis in knee osteoarthritis: A systematic review and meta-analysis.

Deng X, Li Y, Li D Medicine (Baltimore). 2025; 104(5):e41389.

PMID: 39889185 PMC: 11789915. DOI: 10.1097/MD.0000000000041389.


Clinical effect of acupuncture on knee osteoarthritis and its effect on p38 MAPK signaling pathway.

Wei Y, Liu L, Ge H Turk J Phys Med Rehabil. 2024; 70(3):335-343.

PMID: 39679112 PMC: 11639502. DOI: 10.5606/tftrd.2024.13186.


Clinical Assessment of Osteoarthritis Pain: Contemporary Scenario, Challenges, and Future Perspectives.

Sethi V, Anand C, Della Pasqua O Pain Ther. 2024; 13(3):391-408.

PMID: 38662319 PMC: 11111648. DOI: 10.1007/s40122-024-00592-8.


References
1.
Kirkley A, Birmingham T, Litchfield R, Giffin J, Willits K, Wong C . A randomized trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2008; 359(11):1097-107. DOI: 10.1056/NEJMoa0708333. View

2.
Bennell K, Hinman R, Metcalf B, Buchbinder R, McConnell J, McColl G . Efficacy of physiotherapy management of knee joint osteoarthritis: a randomised, double blind, placebo controlled trial. Ann Rheum Dis. 2005; 64(6):906-12. PMC: 1755542. DOI: 10.1136/ard.2004.026526. View

3.
Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K . Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986; 29(8):1039-49. DOI: 10.1002/art.1780290816. View

4.
Raynauld J, Goldsmith C, Bellamy N, Torrance G, Polisson R, Belovich D . Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis. Osteoarthritis Cartilage. 2005; 13(2):111-9. DOI: 10.1016/j.joca.2004.10.018. View

5.
Wittenberg R, Schell E, Krehan G, Maeumbaed R, Runge H, Schluter P . First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215]. Arthritis Res Ther. 2006; 8(2):R35. PMC: 1526611. DOI: 10.1186/ar1854. View